xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns="http://www.w3.org/TR/REC-html40">
NOTICE TO READERS: DEFERRAL OF ROUTINE BOOSTER DOSES OF
TETANUS AND DIPHTHERIA TOXOIDS FOR ADOLESCENTS AND ADULTS To assure vaccine
availability for priority indications, all routine Td boosters in adolescents
and adults should be delayed until 2002. Td use should follow existing
recommendations for all other indications.
MMWR 50(20):418,427, 2001. Centers for Disease Control
http://id.medscape.com/38374.rhtml?srcmp=id-060101
GATES BANKROLLS CRUSADE FOR NEW MENINGITIS VACCINE
A foundation created by computer software mogul Bill Gates
is donating $70 million to back the rapid development of a vaccine to prevent
bacterial meningitis epidemics that regularly occur in sub-Saharan Africa,
officials said on Wednesday.
http://id.medscape.com/38426.rhtml?srcmp=id-060101
LOW CORD BLOOD ANTIBODY LEVELS PREDICT OTITIS MEDIA IN
INFANTS
Infants with low cord blood antibody concentrations to
serotype 19F have more episodes of otitis media during the first year of life
than those with higher antibody concentrations, according to a report in the
May issue of the Archives of OtolaryngologyHead and Neck Surgery.
http://id.medscape.com/38382.rhtml?srcmp=id-060101
PROBIOTIC MILK MAY REDUCE RESPIRATORY INFECTIONS IN CHILDREN
Milk containing Lactobacillus GG, given to children in
daycare facilities, appears to slightly reduce the rate and severity of
respiratory infections, according to a report in the June 2nd issue
of the British Medical Journal.
http://id.medscape.com/38521.rhtml?srcmp=id-060101
NSAIDS DO NOT INCREASE RISK OF NECROTIZING GROUP A
STREPTOCOCCAL INFECTIONS
Administration of nonsteroidal anti-inflammatory drugs
(NSAIDs) to children with primary varicella infection does not increase the
risk of necrotizing group A streptococcal (GAS) infections, according to a
report in the May issue of Pediatrics.
http://id.medscape.com/38389.rhtml?srcmp=id-060101
EUROPE TAKES FURTHER STEPS TO IMPROVE VIRAL SAFETY OF
PLASMA PRODUCTS
Further measures to reduce the risk of contamination of
plasma products by hepatitis A and parvovirus B19 have been recommended by a
European Medicines Evaluation Agency (EMEA) working party.
http://id.medscape.com/38437.rhtml?srcmp=id-060101
ALL
INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR
GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE
KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED
AS PROVIDING MEDICAL OR LEGAL ADVICE. THE DECISION WHETHER OR NOT TO
VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU
ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.